379 related articles for article (PubMed ID: 15705348)
1. Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression.
Pfennig A; Kunzel HE; Kern N; Ising M; Majer M; Fuchs B; Ernst G; Holsboer F; Binder EB
Biol Psychiatry; 2005 Feb; 57(4):336-42. PubMed ID: 15705348
[TBL] [Abstract][Full Text] [Related]
2. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
Binder EB; Künzel HE; Nickel T; Kern N; Pfennig A; Majer M; Uhr M; Ising M; Holsboer F
Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
[TBL] [Abstract][Full Text] [Related]
3. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
Friess E; Schmid D; Modell S; Brunner H; Lauer CJ; Holsboer F; Ising M
J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
Owashi T; Otsubo T; Oshima A; Nakagome K; Higuchi T; Kamijima K
Psychoneuroendocrinology; 2008 Feb; 33(2):152-61. PubMed ID: 18068306
[TBL] [Abstract][Full Text] [Related]
5. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
de Kloet C; Vermetten E; Lentjes E; Geuze E; van Pelt J; Manuel R; Heijnen C; Westenberg H
Psychoneuroendocrinology; 2008 Apr; 33(3):313-20. PubMed ID: 18215470
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of hypothalamic-pituitary-adrenal system response to a combined dexamethasone-CRH test in multiple sclerosis.
Grasser A; Möller A; Backmund H; Yassouridis A; Holsboer F
Exp Clin Endocrinol Diabetes; 1996; 104(1):31-7. PubMed ID: 8750568
[TBL] [Abstract][Full Text] [Related]
7. Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II.
Lammers CH; Garcia-Borreguero D; Schmider J; Gotthardt U; Dettling M; Holsboer F; Heuser IJ
Biol Psychiatry; 1995 Dec; 38(12):803-7. PubMed ID: 8750038
[TBL] [Abstract][Full Text] [Related]
8. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?
Ising M; Horstmann S; Kloiber S; Lucae S; Binder EB; Kern N; Künzel HE; Pfennig A; Uhr M; Holsboer F
Biol Psychiatry; 2007 Jul; 62(1):47-54. PubMed ID: 17123470
[TBL] [Abstract][Full Text] [Related]
9. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
[TBL] [Abstract][Full Text] [Related]
10. The combined dexamethasone-suppression/CRH-stimulation test in alcoholics during and after acute withdrawal.
Hundt W; Zimmermann U; Pöttig M; Spring K; Holsboer F
Alcohol Clin Exp Res; 2001 May; 25(5):687-91. PubMed ID: 11371718
[TBL] [Abstract][Full Text] [Related]
11. Salivary cortisol and suicidal behavior--a follow-up study.
Lindqvist D; Isaksson A; Träskman-Bendz L; Brundin L
Psychoneuroendocrinology; 2008 Sep; 33(8):1061-8. PubMed ID: 18672335
[TBL] [Abstract][Full Text] [Related]
12. A combined dexamethasone/corticotropin-releasing hormone test in patients with chronic PTSD--first preliminary results.
Muhtz C; Wester M; Yassouridis A; Wiedemann K; Kellner M
J Psychiatr Res; 2008 Jul; 42(8):689-93. PubMed ID: 17884095
[TBL] [Abstract][Full Text] [Related]
13. Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I.
Schmider J; Lammers CH; Gotthardt U; Dettling M; Holsboer F; Heuser IJ
Biol Psychiatry; 1995 Dec; 38(12):797-802. PubMed ID: 8750037
[TBL] [Abstract][Full Text] [Related]
14. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
Künzel HE; Ackl N; Hatzinger M; Held K; Holsboer-Trachsler E; Ising M; Kaschka W; Kasper S; Konstantinidis A; Sonntag A; Uhr M; Yassouridis A; Holsboer F; Steiger A
J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
[TBL] [Abstract][Full Text] [Related]
15. Persistent cognitive impairment in depression: the role of psychopathology and altered hypothalamic-pituitary-adrenocortical (HPA) system regulation.
Reppermund S; Zihl J; Lucae S; Horstmann S; Kloiber S; Holsboer F; Ising M
Biol Psychiatry; 2007 Sep; 62(5):400-6. PubMed ID: 17188252
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test.
Künzel HE; Binder EB; Nickel T; Ising M; Fuchs B; Majer M; Pfennig A; Ernst G; Kern N; Schmid DA; Uhr M; Holsboer F; Modell S
Neuropsychopharmacology; 2003 Dec; 28(12):2169-78. PubMed ID: 12931142
[TBL] [Abstract][Full Text] [Related]
17. HPA axis functioning associated with transition to psychosis: combined DEX/CRH test.
Thompson KN; Berger G; Phillips LJ; Komesaroff P; Purcell R; McGorry PD
J Psychiatr Res; 2007 Aug; 41(5):446-50. PubMed ID: 16403528
[TBL] [Abstract][Full Text] [Related]
18. HPA axis hyperactivity as suicide predictor in elderly mood disorder inpatients.
Jokinen J; Nordström P
Psychoneuroendocrinology; 2008 Nov; 33(10):1387-93. PubMed ID: 18805641
[TBL] [Abstract][Full Text] [Related]
19. Emotional exhaustion and overcommitment to work are differentially associated with hypothalamus-pituitary-adrenal (HPA) axis responses to a low-dose ACTH1-24 (Synacthen) and dexamethasone-CRH test in healthy school teachers.
Wolfram M; Bellingrath S; Feuerhahn N; Kudielka BM
Stress; 2013 Jan; 16(1):54-64. PubMed ID: 22564145
[TBL] [Abstract][Full Text] [Related]
20. HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions.
Aihara M; Ida I; Yuuki N; Oshima A; Kumano H; Takahashi K; Fukuda M; Oriuchi N; Endo K; Matsuda H; Mikuni M
Psychiatry Res; 2007 Aug; 155(3):245-56. PubMed ID: 17587554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
